View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Ceva says CLAS vials are proven to be easy to use, practical and eco-friendly and are preferred by 99% of farmers on farm1. They have 33% less impact on the environment from cradle to grave than glass2 and are robust and shock resistant3 for fewer breakages and losses. They are made from a lightweight material to make the vials easier to be transported and handled4 and have an ergonomic ‘grip groove’ for easier handing5.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "Ceva’s CLAS vials are hugely popular with both vets and farmers due to their practicality, ease of use and environmental credentials.
“We are therefore delighted that Ketofen has joined the extensive range of livestock injectables available in CLAS.”
For further information contact your local Ceva territory manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
References
Overall, there has been a 17% decline in Kennel Club registrations of all dogs so far this year.
However, new registrations of Pugs, French Bulldogs and English Bulldogs have declined by 42%, 39% and 34% respectively, putting these three breeds into the list of 'top five fallers' this year.
The Brachycephalic Working Group (BWG), which is made up of vets, national animal welfare organisations, scientists, and dog breed clubs has welcomed the news.
Dan O’Neill, Chair of the BWG said: “The drop in puppy registrations for these flat-faced breeds is a welcome step in the right direction, although these should be seen with some caution.
“We hope this is a sign that more and more puppy buyers, owners and breeders are considering the serious health and welfare implications for flat-faced dogs.
ukbwg.org.uk
CVS has announced its acquisition of the Dovecote Veterinary Hospital, a general and referral practice based in Castle Donington near Derby.
The Dovecote offers a range of referral services including digital X-ray, MRI and CT scanning capability. Its directors, Andrew Robinson, a European RCVS Recognised Specialist in Small Animal Surgery, and Alison Robinson have been appointed joint Clinical Directors.
Dovecote joins ChesterGates Veterinary Specialists in Chester, Norfolk-based Grove Referrals and St David's Veterinary Group in Devon in CVS' referral practice portfolio. The Group also has a new veterinary hospital - Lumbry Park Veterinary Specialists - under construction at Alton, Hampshire; opening in October 2015.
In addition to the Dovecote, CVS has announced the acquisition of further first opinion practices based in Yorkshire and Wales. They are:
Simon Innes, Chief Executive of CVS, said: "These latest acquisitions show continued progress towards our goal of building a strong presence throughout all sectors of veterinary practice. It is a particularly exciting time for our referral team and we are delighted to welcome the team from Dovecote, as well as the other new practices which have joined us recently."
Vets and farmers must do more to improve dairy cow welfare in the UK, according to the British Veterinary Association (BVA). The call comes after careful consideration of major reports and opinions on the welfare of dairy cattle by FAWC (Farm Animal Welfare Council) and EFSA (European Food Safety Authority).
In a new policy statement, released last week, the BVA outlined the need for veterinary surgeons to take an active role in educating farmers and promoting better welfare, as well as working with farming clients towards a 'Herd Welfare Plan' that can be followed alongside the 'Farm Health Plan'.
The BVA says it recognises that some improvements have been made in certain welfare areas, such as longevity, but that issues relating to lameness, mastitis, housing and infectious diseases, such as TB, continue to be of concern.
Veterinary surgeons are well placed to offer help and advice in order to educate farmers on welfare aspects and how they affect herd health, productivity and ultimately, profit.
The policy also addresses issues around breeding for certain traits, which should always be discussed with a vet through a breeding plan, and the challenges of housing dairy herds. The BVA believes much can be done to achieve high welfare standards through good housing.
Finally, the BVA supports retailers who reward farmers financially for improving welfare standards for dairy cows and their calves.
Professor Bill Reilly, President of the BVA, said: "Recent reports have highlighted a number of major concerns about the welfare of dairy cows and their calves, and the BVA feels strongly that vets can take a leading role in addressing these issues.
"Lameness, mastitis, inadequate housing and infectious disease can all lead to poor welfare. Not only is this unacceptable for the animals, but it can be bad for the farmer's business.
"By working together, vets and farmers can and should do more to improve dairy cow welfare through Herd Welfare Plans, breeding plans and improved housing conditions."
Keith Cutler, President of the British Cattle Veterinary Association (BCVA), added: "While the UK enjoys higher standards of dairy cow welfare than many other countries, there are still some issues that need to be tackled.
"Vets and farmers need to work together to address problems. In my experience most farmers are pleased to discuss issues with their vets and then work in conjunction to improve the health and welfare, and ultimately the productivity and profitability, of their herds."
The events will cover a range of subjects designed to boost morale, positively influence wellbeing and reduce the impact of seasonal affective disorder (SAD). They will also demonstrate how to support employees and colleagues to ensure work is sustainable, productive and enjoyable and guide veterinary professionals through mechanisms to make working life a more positive experience, despite the current climate.
The series will feature 30-minute presentations by wellbeing professionals such as sports psychiatrist, Dr Claire Gillvray (pictured right), human factors specialist, Dan Tipney, and occupational psychologist, Prof Elinor O’Connor.
The full programme is:
Liz Barton, co-founder of WellVet, said: “WellVet exists to provide practical tools and a supportive network to help positively influence and improve wellbeing and boost morale. This programme of events is designed to answer specific challenges we’re experiencing – now more than ever in veterinary teams, and to bring us together for a bit of festive cheer."
Emma McAnally, territory manager at Boehringer Ingelheim. said: “During these challenging times, work and life in general can often seem overwhelming. We are delighted to support the WellVet Winter Wellbeing series to help improve wellbeing both in the work and home environments.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
Merck and sanofi-aventis, owners of Merial and Intervet Schering-Plough respectively, have announced that they will not be combining the two animal health businesses as had been planned since March 2010.
In a joint announcement today, the companies said they are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process. The companies agreed that ending their plan is in the best interests of both companies and their respective shareholders, as well as the employees of Merial and Intervet/Schering Plough.
Sanofi-aventis says it remains strongly committed to its animal health activities, which it will continue to develop under the Merial brand as a growth platform of its diversified health business. Merial is one of the world's leading innovation-driven animal healthcare companies dedicated to research, development, manufacturing and commercialization of veterinary pharmaceuticals and vaccines, that generated annual sales of US $ 2.6 billion in 2010.
Merck has also stated its commitment to animal health and Intervet/Schering-Plough, a global leader in the research, development, manufacturing and sale of veterinary medicines which generated sales of US $ 2.9 billion in 2010
As a result of termination, both Merial and Intervet/Schering-Plough will continue to operate independently.
The RSPCA reports that it has saved nearly 400 animals from flooding, including 40 fish, in the last 3 days alone.
The koi carp were rescued from a pond in Wraysbury, Berkshire, which was being overcome by rising floodwater.
Other rescues have included:
The charity says its flood rescue team has helped 586 animals affected by floods since Jan, with 386 of those in the last three days alone. Their efforts were praised by Labour leader Ed Milliband yesterday, who was at the scene with an RSPCA water rescue team in Wraysbury.
RSPCA flood rescue co-ordinator Jason Finch said: "The water rescue teams on the ground are doing an amazing job with limited resources. We will continue to do everything we can to help animals, and humans, during this difficult time and are so grateful for all the support our workers have received from the public."
Photograph courtesy RSPCA
Elanco Animal Health has launched #PetMagicMoments, a social media campaign designed to drive engagement between veterinary practices and their clients and encourage customer footfall to veterinary practices.
As part of the #PetMagicMoments campaign, the company is inviting veterinary professionals and pet owners to share some of the magic moments they've had with their pet on Facebook, Twitter and Instagram. There's a weekly prize of a personalised photo cushion for the image that gets the most likes, shares or retweets, and a main prize draw for £500 worth of Forest Holidays’ vouchers.
In addition, Elanco is asking veterinary practice staff to share heart-warming stories that happen in practice, using the hashtag #VetMagicMoments. The practice that shares the most popular post or tweet will win a monthly prize of a £250 restaurant voucher.
Elanco has produced a launch pack to support the campaign and promote it to colleagues and clients. The pack includes:
Matthew Rowe, Milbemax marketing manager at Elanco Animal Health, said: "Facebook users account for 90% of all UK social media users1 with nearly one in four dogs and cats having their own social media feed or page2. Our #PetMagicMoments campaign will build a community of pet owners, vets and vet nurses who share the love they have for their pets, while driving engagement between veterinary practices and their clients on social media and encouraging customer footfall direct to the veterinary practice which will lead to increased revenues for veterinary practices."
Elanco says it will also be sharing worming advice, pet related information, news, statistics and competitions and quizzes, which will all be available for veterinary practices to share via their own social media.
To sign up for the #PetMagicMoments campaign visit www.petmagicmoments.com and download the campaign guide.
For further information, contact your local Elanco Animal Health territory manager.
The service is being led by Isuru Gajanayake, a board-certified specialist in veterinary nutrition. He said: “Since launching our clinical nutrition service last year, we have seen a number of cases in which patients have been either dehydrated or malnourished, sometimes both.
“Working alongside our other services in a truly multidisciplinary approach, we have been able to offer suitable treatment to support a significant number of dogs and cats.
“With the launch of the parenteral nutrition service, we can now expand this offering and, in doing so, become one of only a very few referral centres across the UK to provide this as a specialist service.
“Patients who are given parenteral nutrition will be hospitalised in our advanced intensive care unit to ensure they can be monitored closely by our specialist emergency and critical care (ECC) team, who provide exceptional expertise in critical care and treatment for every patient when they need it most.
Isuru added that the addition of the clinical nutrition and parenteral nutrition services at Willows ensures that there is a much greater emphasis on nutrition and hydration for all patients at the centre, whatever their underlying illness.
For more information, visit www.willows.uk.net or search for Willows Veterinary Centre and Referral Service on Facebook.
The brainchild of Sonya Miles CertAVP(ZM), CertAqV, MRCVS, Just Exotic (www.justexotics.co.uk) offers a range of training webinars, fact sheets, care sheets and ‘how to’ videos developed for veterinary surgeons, nurses and students. The webinars cost between £15 and £55 (depending on the length), and include presentations by Sonya herself, Eliabetta Mancinelli, Agata Witkowska, Louise Ash, Sarah Pellett and others.
Sonya said: “We’ve developed our content to be convenient and affordable. Some of it may also be helpful for clients.
"More content will be added on a regular basis, and please, if there is something you specifically want covered, drop us a line to info@justexotics.co.uk and will we do our best to make sure it becomes available.”
The company says that over that time, it has invested £122 million in sites, equipment and technology, but for some vets and nurses, a lack of training and confidence and a perceived lack of time has been a barrier to getting the most out of it.
The new CVS ‘Equipment Optimisation’ project will focus on CT, X-ray, dental X-ray, microscopy, endoscopy and laparoscopy, aiming to maximise its value and longevity.
The project plans to do this by helping to increase colleague confidence in the equipment’s ability, and to improve its maintenance - thereby reducing down time.
Each CVS practice will select one piece of equipment as a focus area for the next 12 months.
Each practice will create a plan, set project goals and then evaluate and share what works.
To support practices in their work, CVS has created a new clinical projects hub offering information and guidance on equipment set up, use, clinical interpretation, maintenance and troubleshooting.
The company is also offering additional training in the form of in-practice mentoring, radiation protection supervisor training, and a variety of online courses.
Lizzie McLennan Green, CVS Companion Animal UK Veterinary Director, said: “We’ve invested significantly in clinical equipment to improve patient diagnoses.
"And this project will help teams to feel confident in using and maintaining it.
"It offers a huge opportunity to continuously improve; offering better treatment and improved services to our clients and their animals.
“Each practice is being given the chance to select a piece of equipment that best fits their client base, their team and the way they work.
"We’re getting everyone involved from the start to tailor their own project – to make the process more targeted and meaningful.
“And to help colleagues, our clinical projects hub will be the go-to space containing all of the information, tools and support they need to get involved.
"It’ll also allow colleagues to connect with others, share ideas and build confidence as a wider team.”
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
The BSAVA has announced that comic Michael McIntyre has joined the line up for Congress Party Night.
McIntyre will be joining comedian Fred MacAulay and ventriloquist Paul Zerdin
To register for BSAVA, click here.
The VetGDP, which replaced the Professional Development Phase (PDP), provides a period of structured support to aid the transition of newly-registered veterinary surgeons from veterinary studies to life in the workplace.
VetGDP is being rolled out during 2021 and this year’s veterinary graduates will need to enrol on it.
One of the main features of VetGDP is the requirement for a trained VetGDP Adviser to be available in the practice to provide their new graduate with one-to-one, meaningful support and guidance, to help develop their confidence and capabilities.
In order for veterinary surgeons to become VetGDP Advisers they must complete an online training package being developed by the RCVS and formally commit to supporting new graduates.
Practices that have trained VetGDP Advisers and make this commitment will receive the status of an RCVS-Approved Graduate Development Practice.
The original plan was that practices who wish to employ this year’s cohort of graduates should have obtained RCVS-Approved Graduate Development Practice status by June 2021.
This has now been amended in recognition of the additional pressures that veterinary practice teams are under as a result of the pandemic.
Practices who employ graduates this year will now have until December 2021 to achieve this status, provided they have started to work towards RCVS-Approved Graduate Development Practice status and commit to supporting their new graduate while they do so.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “The ongoing pandemic restrictions, specifically changes made by the government to veterinary professionals’ key worker status on 13 January, means that there are now significant additional pressures on practice teams, particularly in terms of staffing, as many members of the profession will be balancing their work with caring responsibilities. We recognise this and, as such, we have updated the timeframe for the completion of our training for VetGDP Advisers.
“I would also like to personally thank the 850 vets who have already registered their interest in becoming VetGDP Advisers. It is very reassuring to see so many members of the profession committed to supporting new members of the profession, and wanting to engage with the training and with VetGDP to help nurture and develop our future vets through their first few years in practice.”
The College will be holding three VetGDP workshops in February. Each workshop will feature the same content, so there’s no need to attend more than one.
They take place on:
The workshops are open to anyone in the veterinary team including veterinary surgeons who may be considering becoming a VetGDP Adviser, practice managers and others involved in graduate recruitment and anyone else who would like to find out more about VetGDP.
The sessions will be interactive and there will be a significant portion of time given over to Q&As. The RCVS Chair of Education Committee, Dr Sue Paterson FRCVS, and Dr Linda Prescott-Clements, will be available to answer any questions which can be submitted live during the event. You can also submit questions as you register for the workshop at: www.rcvs.org.uk/vetgdpworkshops.
For more information, visit: www.rcvs.org.uk/vetgdp
Homeopathy is widely used in livestock, especially to replace or reduce the use of antibiotics in the treatment of infectious diseases, although its use is often seen as controversial. For organic agriculture, homeopathy is even promoted.
In the review, Dr Caroline Doehring and Professor Albert Sundrum from the University of Kassel, Germany, assessed peer-reviewed studies on the efficacy of homeopathy in cattle, pigs and poultry published between 1981 and 2014.
They analysed a total of 52 clinical trials, 34 with cattle, 12 with pigs and six with poultry. They were published in 48 publications.
Of these, 28 concluded that the homeopathic remedy administered was effective, 22 showed no efficacy and 2 were inconclusive.
Only 10 trials provided information on cure rates for the treatments. These varied to a high degree, while the remedy used did not seem to make a big difference.
Trials on pigs were frequently efficacious, while studies with cattle or poultry had a similar distribution of efficacious and non-efficacious treatment.
Double-blind randomised controlled trials reported efficacy of the homeopathic treatment almost as often as they reported lack of it.
Meanwhile, single-blind and non-blind randomised controlled trials, and observational trials were more likely to present evidence of efficacy, suggesting that positive outcomes may be due to bias.
Other study limitations, such as potential conflict of interests, low sample size, risk for selective reporting and bias, were found in the majority of trials.
While some clinical trials showed effectiveness, the authors of the review question the reliability of the evidence, because all studies had a range of limitations. For example, all clinical trials were conducted under very specific conditions and none were repeated under comparable conditions.
Therefore, the authors say the findings cannot be be used to recommend homeopathy: "The current evidence of studies providing evidence in favour of homeopathy lacks reproducibility and therefore cannot claim to have sufficient prognostic validity."
"Due to a lack of prognostic validity, replacing or reducing antibiotics with homeopathy currently cannot be recommended unless evidence of efficacy is reproduced by RCTs and proven in various farm practice conditions."
The CPD event takes place this Thursday 9th April, from 9:30am to 5:30pm, using the Zoom video conferencing platform. The organisers say that the agenda is still being finalised, but will be split into three streams: Farm Animal, Equine and Small Animal.
Confirmed speakers include:
Although the event is free, participants are asked make a voluntary contribution at justgiving.com/fundrasing/vets-for-nhs.
To register for the event, visit www.vetsfornhs.co.uk
Vets for NHS is supported by Boehringer Ingelheim, MSD Animal Health, Nimrod and the Scottish Vet Fair.
CEVA Animal Health has extended its range of injectable anti-infectives with Florkem, a Florfenicol-based antimicrobial for the treatment of respiratory tract infections in cattle and pigs.
According to the company, Florfenicol shows a strong in vitro bactericidal activity against the most common respiratory tract pathogenic bacteria and can be used as a time or dose-dependent bactericidal depending on the target. It also offers very good diffusion in most tissues for an efficient response.
CEVA says Florkem® is very convenient to use: a specifically developed formulation provides for better syringeability, in both warm and cool temperatures, making administration quicker and easier. It is presented in an ergonomic CLAS vial, which is shock resistant, light and easy to handle in the field. This means fewer breakages, which can reduce costs while maintaining efficacy.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
Equine infectious anaemia (EIA) has been detected in a horse in Northumberland following importation from the Netherlands, Defra confirmed today.
The premises is currently under restriction and the infected horse will be humanely destroyed in line with existing regulations. The other horses on the premises are currently subject to epidemiological investigation.
The horse arrived in a group of six horses originating in the Netherlands and all have been tested for EIA as part of routine post-import testing. The other five horses in the group have all tested negative.
Chief Veterinary Officer Nigel Gibbens said: "This again shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy this horse."
Meanwhile, equine welfare charity World Horse Welfare is sending out an urgent plea to all horse owners across the UK and mainland Europe to work together in order to stop the increasing threat from this and a number of other diseases.
According to the charity, this case comes only eight months after the discovery of two horses suffering from the disease, which is notifiable, in Wiltshire. Those horses had been transported across Europe from Romania before being imported into the UK. Since the end of August alone, there have been new outbreaks reported in Northern France (directly linked to horses imported from Romania), the Dordogne area, and Germany.
World Horse Welfare Chief Executive Roly Owers said: "While World Horse Welfare welcomes the news that Defra has acted so promptly in dealing with this case, today's news is extremely concerning and demonstrates the changing environment we're living in. This is a real warning to us that we're sailing far too close to the wind. The concerning question is where these horses came from given that Holland to date has not reported a case of EIA.
"With more and more horses moving across Europe, including the significant trade in low value animals, not just slaughter animals, we're facing an increasing threat from the spread of disease. EIA is endemic in both Romania and Italy; Romania being one of the largest exporters and Italy being the largest importer of horses for slaughter in Europe. In spite of the legal requirement for health certification before exporting horses from Romania, which were tightened in June 2010, there continues to be cases of EIA across Europe.
"World Horse Welfare advises owners to undertake rigorous checks when buying a horse from abroad and is discouraging anyone from importing Romanian horses. Owners should also ensure that any horse they buy or that comes on to their yard has a passport, is checked for a microchip and that isolation and biosecurity measures are strictly followed for any new entry onto the yard. If this disease spreads across the UK it could have catastrophic effects on our horse population. Whether it's a child's pony or Cheltenham Gold Cup winner, disease does not discriminate."
For the trial, the company has partnered with Pennard Vets in Kent, where they're using Google Glass to transmit what the practitioner sees straight to the consulting experts at VetCT.
The remote VetCT specialist is able to view and remotely record, zoom, adjust lighting, annotate and send images back for the wearer of the glasses to view.
They are also able to discuss the case live with team in the clinic.
As part of the trial, images streamed via the glasses are being compared against those shot on a higher resolution mobile phone.
Director and Innovation Lead at VetCT, Julien Labruyère said: “We have a tremendous resource of specialist knowledge and expertise within our global team, and are exploring new ways to maximise the potential benefits of real-time clinical mentoring, teaching and case support.
"This first step we have taken with Google Glass marks the start of an exciting journey to make smart glasses technology useful to help vets in practice."
Caroline Collins, Director at Pennard Vets, said: “Trialling the glasses has been a fascinating exercise. We’re now looking at cases where we could see the most benefit from real-time specialist feedback and hands-free capability. It could be a real game-changer in some situations, for example with remote guidance of patient examinations or complex procedures.”
To learn more about VetCT visit www.vet-ct.com.
Henry won the title in recognition of his work tackling bird flu, as the outbreak of this devastating disease spread across the country this summer.
A total of 140 nominations were received for this year’s Zoetis-sponsored award, which celebrates vets who have made a significant impact in the first stages of their professional career.
The judging panel comprised BVA President Anna Judson, Royal College of Veterinary Surgeons (RCVS) President Sue Paterson, National Veterinary Lead Ruminant and Equine at Zoetis UK Ally Ward, and last year’s award winner vet Hannah Hunt.
In addition to his work tackling bird flu, the judges also acknowledged Henry’s role in encouraging other young vets to join the poultry industry.
After graduating from the Royal Veterinary College (RVC) in 2018, he began working at Crowshall Veterinary Services, Norfolk, providing dedicated consultancy and Official Veterinarian (OV) provision to the poultry/gamebird industry across Great Britain and internationally.
This has seen him working through the recent bird flu outbreaks, holding multiple OV panels, and preparing for export changes associated with Brexit.
Henry is also a mental health first aider and trustee of regional rural mental health charity You Are Not Alone (YANA), deputy rotation lead for the new RVC poultry rotation, which takes its first students in 2024, and is also co-lead of his practice green group through which he has steered his practice to the top Green accreditation for sustainability with Investors in the Environment.
In his role as external lecturer for the RVC, Henry provides opportunities to engage with avian population medicine for new members of the profession.
Henry said: “To be named BVA Young Vet of the Year is a huge honour and it means all the more having heard about the outstanding work, dedication and skills of the other two finalists.
I’m delighted that after a challenging few years the poultry sector has been highlighted tonight, as all those involved have worked tirelessly to overcome the largest animal health outbreak the UK has experienced in recent times - I hope that winning this award will encourage more young vets to consider joining us in the poultry sector.
"It’s extremely rewarding work.”
Henry was shortlisted alongside vet Rebecca Hampson, who co-founded animal welfare charity Veterinary Education Malawi, and equine vet Camilla Church, who set up her own practice, Perth Equine Vets.
BVA President Anna Judson said: “The standard of nominations this year was outstanding. It sounds cliché, but we really did have our work cut out when choosing the finalists.”
Photo: Young Vet of the Year Henry Lamb with finalists Rebecca Hampson, BVA President Anna Judson and Camilla Church.jpg
Phacoemulsification uses ultrasonic energy to emulsify and remove the cataract through small incisions on the eye, instead of requiring ophthalmologists to open 180 degrees of the eye.
It also allows for the placement of an artificial intraocular lens for the best possible visual outcome for patients.
This, says Chestergates, significantly reduces recovery time and complication rates compared to traditional methods.
Chestergates has invested over £130,000 in human-grade ophthalmic technology for its phacoemulsification patients, including an Alcon Centurion Vision System with Active Sentry Handpiece, a next-generation operating microscope, portable electroretinography (ReteVet), a Chromatic Pupillary Light Reflex (CPLR) tester and high-frequency ultrasound probes for ocular imaging.
Endika said: “Chestergates is one of the few specialist veterinary hospitals in the region to offer this new technique.
"It allows for safer, more precise removal of cataracts and placement of artificial intraocular lenses - restoring vision with minimal recovery time.
"We hope it will be of great benefit to pets suffering from cataracts across the region.”
Chestergates is offering fixed pricing for its new cataract surgery service using phacoemulsification.
The cost is £4,550 for one eye and £5,550 for both eyes, including all preoperative tests (electroretinography, gonioscopy, ultrasound, blood work), surgery, 24-hour hospitalisation, take-home medications, and 8 weeks of postoperative care.
It is not the first time Roundhouse Referrals has innovated in this area. Last year, it launched the first 'Fixed Price TPLO' - a guarantee that pet owners will have no additional costs, should complications arise and further treatment be required following surgery.
Ross Allan, RCVS Advanced Practitioner in Small Animal Surgery and Surgical Lead at Roundhouse Referrals, said: "We loved the idea of providing price certainty for referral clients, allowing those with no or lower levels of insurance to access our services and plan their finances. We also realised that in putting 'Fixed Price Fix' first and foremost we are also immediately highlight the possibility of complications and we felt the very best way to provide context for owners and referring vets would be to be open about our outcomes."
Following on from this Roundhouse Referrals has published the first of what it says will be a series of reports on TPLO+ clinical outcomes and customer satisfaction.
Ross said: "I think we're the first in Scotland to publish this kind of information outside scientific journals in a way that is easily accessible for pet owners, maybe in the whole of the UK."
The clinical outcome data was collected using a previously published questionnaire which enabled clients to give feedback on their pet’s recovery and status following their TPLO+ surgery.
According to Roundhouse, the results show that over 97% of dog owners rated their pets’ outcome as either excellent (85.29%) or good (11.76%) based on the first 70 TPLO+ surgeries performed. A figure which Ross says compares favourably with studies that have been previously published.
Additionally, 94.1% of pet owners agreed that if faced with having to make a similar decision again, they would choose to have the TPLO+ surgery done at Roundhouse Referrals, compared to 84.6% of owners in the previous study.
The results from the Customer Satisfaction Questionnaire showed that 100% of Roundhouse Referrals’ clients felt supported throughout the referral process, 96.97% of clients felt that the TPLO+ surgery was adequately explained and 100% would recommend Roundhouse Referrals to a friend or colleague.
Ross said: "Pet owners whose dogs’ had been through TPLO+ surgery and rehabilitation completed this questionnaire, enabling us to start measuring the outcome of the surgery, our aim being to ensure the surgery is optimal for the pet, and that owners feel supported throughout the entire surgical journey.
"We are delighted with these results, and will continue to monitor our outcomes and commit to publish our TPLO+ clinical outcome and customer satisfaction questionnaire results in the months and years ahead".
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
The offer is timed to coincide with the expected increase in canine pruritis as the warmer weather leads to increased levels of common allergens such as pollen, dust mites and flea bites.
Each practice that buys five packs of Apoquel will get one free, subject to a minimum qualifying purchase.
Apoquel is a fast-acting oral therapy for the treatment of canine pruritus associated with allergic dermatitis.
Zoetis says its novel mechanism of action on the Janus Kinase (JAK) enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
For more information about the Apoquel Spring offer, contact your Zoetis account manager.